IL259562B - Aminophosphine derivatives for the prevention and treatment of eye pain - Google Patents

Aminophosphine derivatives for the prevention and treatment of eye pain

Info

Publication number
IL259562B
IL259562B IL259562A IL25956218A IL259562B IL 259562 B IL259562 B IL 259562B IL 259562 A IL259562 A IL 259562A IL 25956218 A IL25956218 A IL 25956218A IL 259562 B IL259562 B IL 259562B
Authority
IL
Israel
Prior art keywords
preventing
treating eye
eye pain
aminophosphinic
derivatives
Prior art date
Application number
IL259562A
Other languages
English (en)
Hebrew (he)
Other versions
IL259562A (en
Original Assignee
Pharmaleads
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaleads filed Critical Pharmaleads
Publication of IL259562A publication Critical patent/IL259562A/en
Publication of IL259562B publication Critical patent/IL259562B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/724Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts, ocular implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL259562A 2015-11-30 2018-05-23 Aminophosphine derivatives for the prevention and treatment of eye pain IL259562B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1561598A FR3044227B1 (fr) 2015-11-30 2015-11-30 Derives aminophosphiniques pour la prevention et le traitement des douleurs oculaires
PCT/EP2016/079285 WO2017093322A1 (fr) 2015-11-30 2016-11-30 Dérivés aminophosphiniques pour la prévention et le traitement des douleurs oculaires

Publications (2)

Publication Number Publication Date
IL259562A IL259562A (en) 2018-07-31
IL259562B true IL259562B (en) 2020-08-31

Family

ID=55346018

Family Applications (1)

Application Number Title Priority Date Filing Date
IL259562A IL259562B (en) 2015-11-30 2018-05-23 Aminophosphine derivatives for the prevention and treatment of eye pain

Country Status (15)

Country Link
US (2) US20180344753A1 (enExample)
EP (1) EP3383403B1 (enExample)
JP (1) JP6889176B2 (enExample)
KR (1) KR102657652B1 (enExample)
CN (2) CN112121008A (enExample)
BR (1) BR112018010007A2 (enExample)
CA (1) CA3006365A1 (enExample)
DK (1) DK3383403T3 (enExample)
ES (1) ES2773148T3 (enExample)
FR (1) FR3044227B1 (enExample)
IL (1) IL259562B (enExample)
MX (1) MX382921B (enExample)
TW (1) TWI729039B (enExample)
WO (1) WO2017093322A1 (enExample)
ZA (1) ZA201804037B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9993427B2 (en) * 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
US11090317B2 (en) * 2017-03-09 2021-08-17 Pharmaleads Aminophosphinic derivatives for preventing and treating eye inflammation
FR3063635B1 (fr) * 2017-03-09 2019-06-07 Pharmaleads Derives aminophosphiniques pour la prevention et le traitement de l'inflammation oculaire
FR3104581B1 (fr) * 2019-12-11 2021-11-26 Pharmaleads Procédé de préparation industrielle du sel disodique de ((2S)-3-([1,1'-biphenyl]-4-yl)-2-((hydroxy((1R)-1-(((1-(isobutyryloxy)ethoxy)carbonyl)amino)ethyl)phosphoryl) methyl)propanoyl)-L-alanine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0987291A (ja) * 1995-09-26 1997-03-31 Wakamoto Pharmaceut Co Ltd 新規なアラニン誘導体
FR2755135B1 (fr) * 1996-10-25 2002-12-27 Inst Nat Sante Rech Med Nouveaux derives d'(alpha-aminophosphino)peptides, leur procede de preparation et les compositions qui les contiennent
JP2001506652A (ja) * 1996-12-16 2001-05-22 アルコン ラボラトリーズ,インコーポレイテッド 眼の痛みを治療するためのκオピオイド・アゴニストの局所使用
FR2777780B1 (fr) * 1998-04-22 2001-05-04 Inst Nat Sante Rech Med Derives d'(alpha-aminophosphino) peptides, leur procede de preparation et les compositions qui les contiennent
FR2934267B1 (fr) * 2008-07-23 2010-08-13 Pharmaleads Derives aminophosphiniques utiles dans le traitement de la douleur
FR2934627B1 (fr) 2008-07-29 2010-08-13 Paul Marie Bernard Dispositif de positionnement et de calage d'un garde corps escamotable sur plateforme support de banches
CA2901208A1 (en) * 2013-02-13 2014-08-21 Novartis Ag Topical ocular analgesic agents

Also Published As

Publication number Publication date
MX2018006580A (es) 2018-08-01
CN112121008A (zh) 2020-12-25
EP3383403B1 (fr) 2019-12-25
BR112018010007A2 (pt) 2018-11-21
JP6889176B2 (ja) 2021-06-18
US10688113B2 (en) 2020-06-23
FR3044227B1 (fr) 2017-11-24
TW201726146A (zh) 2017-08-01
TWI729039B (zh) 2021-06-01
KR20180095555A (ko) 2018-08-27
FR3044227A1 (fr) 2017-06-02
CN108289901B (zh) 2021-05-04
WO2017093322A1 (fr) 2017-06-08
ZA201804037B (en) 2020-07-29
DK3383403T3 (da) 2020-03-16
IL259562A (en) 2018-07-31
MX382921B (es) 2025-03-13
KR102657652B1 (ko) 2024-04-15
HK1259181A1 (zh) 2019-11-29
US20180344753A1 (en) 2018-12-06
CA3006365A1 (fr) 2017-06-08
CN108289901A (zh) 2018-07-17
US20190167701A1 (en) 2019-06-06
EP3383403A1 (fr) 2018-10-10
ES2773148T3 (es) 2020-07-09
JP2018536714A (ja) 2018-12-13

Similar Documents

Publication Publication Date Title
IL269371A (en) Treatment methods
IL251788A0 (en) Stimulation devices and methods for treating dry eye
ZA201705673B (en) Methods for treating skin
IL255780A (en) Therapeutic combinations and methods for treating neoplasia
IL249602A0 (en) Methods and devices for the treatment of posterior ocular disorders
EP3171928A4 (en) Stimulation patterns for treating dry eye
ZA201700416B (en) Methods for treating or preventing ophthalmological conditions
GB201502137D0 (en) Treatment
PT4215527T (pt) Composições e métodos para tratar a degradação retinal
PT3393579T (pt) Sistema de tratamento ocular
IL262825A (en) Tetrahydropyridine and tetrahydropyrimidine substances, preparations containing them and their use for pain treatment
SG11201800734QA (en) System and process for retina phototherapy
ZA201804037B (en) Aminophosphinic derivatives for preventing and treating eye pain
GB201604658D0 (en) Treatment for pain
ZA202002526B (en) New alcoxyamino derivatives for treating pain and pain related conditions
IL255012A0 (en) Preparations and methods for treating skin conditions
GB201718985D0 (en) Treatment
PT3519050T (pt) Composições para o tratamento de condições oftálmicas
ZA201906154B (en) Aminophosphinic derivatives for preventing and treating eye inflammation
GB201503008D0 (en) Treatment
SG11202005278PA (en) Compounds for treating eye diseases and methods thereof
GB201713650D0 (en) Treatment
GB201706955D0 (en) Treatment
GB201505205D0 (en) Treatment for pain
GB201504688D0 (en) Treatment for pain

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed